CMS doesn’t care enough about patient reported outcomes like Quality of Life to incentivize collecting it as a quality measure, and manufacturers don’t care enough to fund the additional analysis that is needed.
With the gutting of the bonus payments originally possible in MIPS, the small upwards fee adjustments available under MIPS can’t adjust for this, and the cost of complying with the Quality Payment Program (QPP) is exacerbating the problem.
Because if you become subject to MIPS the following year, you can get extra points for having improved in a category where your performance was not so great.
There is enormous pressure to keep the healthcare industry’s economic engine running at full throttle… but it’s a short-term strategy that is doomed to fail.
Expert testimony is an obligation for practitioners if they have the ability and training. I don’t like it but I do it.
It is now considered negligent for practitioners to try navigating the treacherous sea of real world practice without a registry to monitor and improve performance. Thanks to Codman, the surgeons had about 100 years head start. We have a lot of catching up to do.
There’s a lot of back and forth about the Merit-based Incentive Payment System (MIPS), and it’s hard to decide whether it’s good news or bad news.